• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and

tetano

Editor, Senior Moderator
PLoS Biol


. 2022 May 31;20(5):e3001643.
doi: 10.1371/journal.pbio.3001643. eCollection 2022 May.
Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes


Ayesa Syenina[SUP] 1 2 [/SUP], Esther S Gan[SUP] 1 [/SUP], Justin Z N Toh[SUP] 2 3 [/SUP], Ruklanthi de Alwis[SUP] 1 2 [/SUP], Lowell Z Lin[SUP] 1 [/SUP], Christine Y L Tham[SUP] 1 2 [/SUP], Jia Xin Yee[SUP] 1 2 [/SUP], Yan Shan Leong[SUP] 1 2 [/SUP], Huizhen Sam[SUP] 4 [/SUP], Charlene Cheong[SUP] 4 [/SUP], Yii Ean Teh[SUP] 4 [/SUP], Ian L E Wee[SUP] 4 [/SUP], Dorothy H L Ng[SUP] 4 [/SUP], Kuan Rong Chan[SUP] 1 [/SUP], Jean X Y Sim[SUP] 4 [/SUP], Shirin Kalimuddin[SUP] 1 4 [/SUP], Eugenia Z Ong[SUP] 1 2 [/SUP], Jenny G Low[SUP] 1 2 4 [/SUP], Eng Eong Ooi[SUP] 1 2 4 5 [/SUP]



Affiliations

Abstract

Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown remarkable effectiveness. However, systemic adverse events (AEs), such as postvaccination fatigue, are prevalent following mRNA vaccination, and the underpinnings of which are not understood. Herein, we found that higher baseline expression of genes related to T and NK cell exhaustion and suppression were positively correlated with the development of moderately severe fatigue after Pfizer-BioNTech BNT162b2 vaccination; increased expression of genes associated with T and NK cell exhaustion and suppression reacted to vaccination were associated with greater levels of innate immune activation at 1 day postvaccination. We further found, in a mouse model, that altering the route of vaccination from intramuscular (i.m.) to subcutaneous (s.c.) could lessen the pro-inflammatory response and correspondingly the extent of systemic AEs; the humoral immune response to BNT162b2 vaccination was not compromised. Instead, it is possible that the s.c. route could improve cytotoxic CD8 T-cell responses to BNT162b2 vaccination. Our findings thus provide a glimpse of the molecular basis of postvaccination fatigue from mRNA vaccination and suggest a readily translatable solution to minimize systemic AEs.
 
Back
Top Bottom